Get started
Author

Yi-Hung Ou

Observed name: Yi‐Hung Ou
ORCID: 0000-0002-9909-7791
Observed ORCID: 0000-0002-9909-7791
OpenAlex ID: A5035558177
Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase
2015 · Carlos T. Pineda, Saumya Ramanathan, et al. · Cell · 400
PDF
RalB and the Exocyst Mediate the Cellular Starvation Response by Direct Activation of Autophagosome Assembly
2011 · Brian O. Bodemann, Anthony Orvedahl, et al. · Cell · 326
PDF
Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood
2012 · Melina Herman, Michael Ciancanelli, et al. · The Journal of Experimental Medicine · 292
PDF
TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic Transformation
2011 · Yi-Hung Ou, Michael Torres, et al. · Molecular Cell · 237
PDF
p53 C-Terminal Phosphorylation by CHK1 and CHK2 Participates in the Regulation of DNA-Damage-induced C-Terminal Acetylation
2005 · Yi-Hung Ou, Pei-Han Chung, et al. · Molecular Biology of the Cell · 211
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
2007 · Yi‐Hung Ou, Pei‐Han Chung, et al. · The EMBO Journal · 111
PDF
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization
2019 · Ana P. Gomes, Didem Ilter, et al. · Cancer Cell · 109
PDF
TTK/hMps1 Participates in the Regulation of DNA Damage Checkpoint Response by Phosphorylating CHK2 on Threonine 68
2004 · Jen-Hsuan Wei, Yi-Fan Chou, et al. · Journal of Biological Chemistry · 99
PDF
TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2017 · Jonathan M. Cooper, Yi-Hung Ou, et al. · Cancer Research · 80
Using Functional Signature Ontology (FUSION) to Identify Mechanisms of Action for Natural Products
2013 · Malia B. Potts, Hyun Seok Kim, et al. · Science Signaling · 74
Prdm13 Mediates the Balance of Inhibitory and Excitatory Neurons in Somatosensory Circuits
2013 · Joshua C. Chang, David M. Meredith, et al. · Developmental Cell · 71
PDF
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B
2015 · Malia B Potts, Elizabeth A McMillan, et al. · Nature Chemical Biology · 67
iPSC-Derived CAR-Gamma Delta T with Novel Combinatorial KO Demonstrated Extended Longevity and Profound Anti-Tumor Efficacy without Cytokine Support in Preclinical Studies
2024 · Jhang-Sian Yu, Chia-Hung Lin, et al. · Blood · 3
PDF
Abstract 5573: ACE1831: A novel allogeneic αCD20-conjugated Vδ2 gamma delta T product for non-Hodgkin’s lymphoma
2022 · Tai-Sheng Wu, Hao-Kang Li, et al. · Cancer Research · 1
Abstract A04: TBK1 as a novel mediator of K-Ras driven pancreatic cancer
2014 · Victoria H. Burton, Yi-Hung Ou, et al. · Molecular Cancer Research · 1
Discovery of the Unique GMP-Grade iPSC Clones That Give Rise to Functional, High Purity, Matured CD8 Alpha Beta T or Gamma Delta T with Exponential Expansion Capacity
2024 · Ying-Tsen Tung, Chih-Lung Chen, et al. · Blood
Table S3 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
Figure S3 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
Figure S3 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
PDF
Figure S4 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
Table S2 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
Table S1 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
Figure S1 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
PDF
Figure S2 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
Figure S1 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer
2023 · Jonathan M. Cooper, Yi-Hung Ou, et al.
Works count: 30
Citation count: 2,071
H-index: 12
I10-index: 12
Year
Topic
Type